GlycoMimetics

+$0.0021 (+0.35%) As of 4:36 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GlycoMimetics and other ETFs, options, and stocks.

About GLYC

GlycoMimetics, Inc. engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. It develops proprietary glycomimetics that inhibit disease related functions of carbohydrates.

CEO
Harout Semerjian
Employees
52
Headquarters
Rockville, Maryland
Founded
2003

GLYC Key Statistics

Market cap
31.96M
Price-Earnings ratio
—
Dividend yield
—
Average volume
174.19K
High today
$0.635
Low today
$0.6096
Open price
$0.6289
Volume
6.81K
52 Week high
$2.50
52 Week low
$0.51

GLYC Earnings

-$0.34
-$0.23
-$0.11
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure